Pharis Mohideen, CMO at Tempest Therapeutics, holds 81.15K shares in DBV Technologies SA - American (Ticker: DBVT), holds 7.44K shares in Tempest Therapeutics (Ticker: TPST). Most recently, Pharis Mohideen Sold ― shares of DBV Technologies SA - American on May 29, 2024 for an estimated value of 1.42K.